Filing Flows › Organon (OGN) › R&D spending
Organon (OGN) R&D spending by quarter
Organon's R&D spending was $83.0M in Q3 2026 (third quarter 2026), -8% from Q2 2026. Over the last 7 quarters it ranged from $83.0M (Q3 2026) to $96.0M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $83.0M | -8% | -1% |
| Q2 2026 | $90.0M | -3% | -5% |
| Q1 2026 | $93.0M | +2% | -3% |
| Q4 2025 | $91.0M | +8% | — |
| Q3 2025 | $84.0M | -12% | — |
| Q2 2025 | $95.0M | -1% | — |
| Q1 2025 | $96.0M | — | — |
Q3 2026 at a glance
Organon, Q3 2026: revenue $1.6B (-2% year over year), operating margin 16.2%, net earnings $164M, operating cash flow $370M. The chart follows the revenue to costs, profit and cash.
Questions
What is Organon's R&D spending?
Organon's R&D spending was $83.0M in Q3 2026 (third quarter 2026), -8% from Q2 2026.
How has Organon's R&D spending changed?
Over the last 7 quarters it ranged from $83.0M (Q3 2026) to $96.0M (Q1 2025).